Literature DB >> 9803959

Issues and answers in stroke care.

J van Gijn1, M S Dennis.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9803959     DOI: 10.1016/s0140-6736(98)90091-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Combination treatment with VELCADE and low-dose tissue plasminogen activator provides potent neuroprotection in aged rats after embolic focal ischemia.

Authors:  Li Zhang; Zheng Gang Zhang; Ben Buller; James Jiang; Yanting Jiang; Danping Zhao; Xianshuang Liu; Dan Morris; Michael Chopp
Journal:  Stroke       Date:  2010-03-04       Impact factor: 7.914

2.  Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke.

Authors:  Woei-Cherng Shyu; Shinn-Zong Lin; Ming-Fu Chiang; Der-Cherng Chen; Ching-Yuan Su; Hsiao-Jung Wang; Ren-Shyan Liu; Chang-Hai Tsai; Hung Li
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

3.  Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial.

Authors:  Woei-Cherng Shyu; Shinn-Zong Lin; Chau-Chin Lee; Demeral David Liu; Hung Li
Journal:  CMAJ       Date:  2006-03-03       Impact factor: 8.262

4.  Sodium-dependent vitamin C transporter 2 (SVCT2) expression and activity in brain capillary endothelial cells after transient ischemia in mice.

Authors:  Burkhard Gess; Sevgi Sevimli; Jan-Kolja Strecker; Peter Young; Wolf-Rüdiger Schäbitz
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

5.  Focal cerebral ischemia model by endovascular suture occlusion of the middle cerebral artery in the rat.

Authors:  Kutluay Uluç; Amrendra Miranpuri; Gregory C Kujoth; Erinç Aktüre; Mustafa K Başkaya
Journal:  J Vis Exp       Date:  2011-02-05       Impact factor: 1.355

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.